NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017
William G. Wierda(The University of Texas MD Anderson Cancer Center), Hema Sundar(National Comprehensive Cancer Network), Joachim Yahalom(Unknown), Leo I. Gordon(Northwestern University), Paolo F. Caimi(University Hospitals Seidman Cancer Center), Nancy L. Harris(World Resources Institute), Oliver W. Press(Fred Hutch Cancer Center), Thomas M. Habermann(Mayo Clinic in Arizona), Michael G. Martin(University of Tennessee Health Science Center), Luis Fayad(The University of Texas MD Anderson Cancer Center), Rachel Rabinovitch(University of Colorado Boulder), Susan Krivacic(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Erin Reid(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Lubomir Sokol(Moffitt Cancer Center), Pierluigi Porcu(Thomas Jefferson University), Kenneth B. Roberts(University of North Carolina at Chapel Hill), Ranjana H. Advani(Stanford Medicine), Andrew D. Zelenetz(Memorial Sloan Kettering Cancer Center), Francisco J. Hernandez‐Ilizaliturri(Roswell Park Comprehensive Cancer Center), Charalambos Andreadis(University of California, San Francisco), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Richard T. Hoppe(Stanford Medicine), Nancy L. Bartlett(Washington University in St. Louis), Mark Kaminski(Sheba Medical Center), Julie M. Vose(University of Nebraska Medical Center), Erin D. Snyder(Moffitt Cancer Center), Nishitha Reddy(Vanderbilt University), Ann S. LaCasce(Otsuka (Japan)), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Youn H. Kim(Stanford University), John C. Byrd, Richard I. Fisher(University of Rochester), Mary A. Dwyer(National Comprehensive Cancer Network), Auayporn Nademanee(City Of Hope National Medical Center), Martha Glenn(Huntsman Cancer Institute), Jeremy S. Abramson(Massachusetts General Hospital), Lode J. Swinnen(Johns Hopkins University), Chris R. Kelsey(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 62
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k